Drug Chatter -- Tracking biopharma stock chatter

Profile for Acorda Therapeutics, Inc. (ACOR)

« Back to company index

ACOR Chatter Timeline

Stock Ticker for ACOR

Most Active Tweeters for ACOR

UserTweets
@ConsumerFeed 25
@AmericanBanking 25
@TickerReport 24
@intercooleronli 20
@CFinancialNews 18

Recent Tweets for ACOR

dispatchtribune @dispatchtribune
Leerink Swann Lowers Acorda Therapeutics, Inc. $ACOR Price Target to $18.00 https://t.co/Ytq2nQKP6R
November 19th 2017, 1:11pm
chaffeybreeze @chaffeybreeze
Acorda Therapeutics, Inc. $ACOR Downgraded by Stifel Nicolaus https://t.co/EO9oVh31nQ
November 19th 2017, 11:11am
IRAMarketReport @IRAMarketReport
Acorda Therapeutics, Inc. $ACOR Downgraded by Stifel Nicolaus https://t.co/bFn2TiWf4Y
November 19th 2017, 11:11am
TickerReport @TickerReport
J P Morgan Chase & Co Cuts Acorda Therapeutics, Inc. $ACOR Price Target to $19.00 https://t.co/mNldxJtZPO
November 19th 2017, 10:11am
dailymailtimes @dailymailtimes
Leerink Swann Lowers Acorda Therapeutics, Inc. $ACOR Price Target to $18.00 https://t.co/Ovt8MoTZNn
November 19th 2017, 9:11am
TickerReport @TickerReport
J P Morgan Chase & Co Cuts Acorda Therapeutics, Inc. $ACOR Price Target to $19.00 https://t.co/UmhDF9BWIY
November 19th 2017, 9:11am
emq_news @emq_news
J P Morgan Chase & Co Cuts Acorda Therapeutics, Inc. $ACOR Price Target to $19.00 https://t.co/x7X0kPbsb8
November 19th 2017, 9:11am
midetimes @midetimes
Leerink Swann Lowers Acorda Therapeutics, Inc. $ACOR Price Target to $18.00 https://t.co/PO0UvwcbB6
November 19th 2017, 9:11am
dailypoliticaln @dailypoliticaln
Leerink Swann Lowers Acorda Therapeutics, Inc. $ACOR Price Target to $18.00 https://t.co/mhYUR3eBqc
November 19th 2017, 9:11am
WKRBNews @WKRBNews
Leerink Swann Lowers Acorda Therapeutics, Inc. $ACOR Price Target to $18.00 https://t.co/145U3kbC1P
November 19th 2017, 9:11am
storminvestor @storminvestor
Oppenheimer Holdings, Inc. Analysts Give Acorda Therapeutics, Inc. $ACOR a $18.00 Price Target https://t.co/ZlZSpggy9q
November 19th 2017, 9:11am
SPNewsAnalysis @SPNewsAnalysis
Oppenheimer Holdings, Inc. Analysts Give Acorda Therapeutics, Inc. $ACOR a $18.00 Price Target https://t.co/2FKt0PT1a1
November 19th 2017, 9:11am
TheMarketsDaily @TheMarketsDaily
Acorda Therapeutics, Inc. $ACOR Rating Reiterated by Cowen and Company https://t.co/lbyY2yAreH
November 19th 2017, 6:11am
storminvestor @storminvestor
Acorda Therapeutics Target of Unusually High Options Trading $ACOR https://t.co/uORXMJyAPB
November 19th 2017, 5:11am
Margare30926081 @Margare30926081
Cambiar Investors Stake in Acorda Therapeutics $ACOR Has Lifted by $488,072 as Market Valuation Declined ...
November 19th 2017, 5:11am
SPNewsAnalysis @SPNewsAnalysis
Acorda Therapeutics Target of Unusually High Options Trading $ACOR https://t.co/cVCLtH1wt5
November 19th 2017, 5:11am
storminvestor @storminvestor
Brokers Offer Predictions for Acorda Therapeutics, Inc.’s Q2 2018 Earnings $ACOR https://t.co/DN7RdBrMkB
November 19th 2017, 5:11am
AmericanBanking @AmericanBanking
Stock Traders Purchase Large Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/OkuS5Ut2OK
November 19th 2017, 2:11am
CFinancialNews @CFinancialNews
Stock Traders Purchase Large Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/FHxeJDAmON
November 19th 2017, 2:11am
AmericanBanking @AmericanBanking
$ACOR - Stock Traders Purchase Large Volume of Put Options on Acorda Therapeutics #ACOR https://t.co/EoXZ7WtLmW
November 19th 2017, 2:11am
intercooleronli @intercooleronli
Stock Traders Purchase Large Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/LNnCFCA2je
November 19th 2017, 2:11am
ConsumerFeed @ConsumerFeed
Stock Traders Purchase Large Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/Ap8siG94dO #acn
November 19th 2017, 2:11am
stocknewstimes @stocknewstimes
Acorda Therapeutics, Inc. $ACOR Given Buy Rating at Cowen and Company https://t.co/UatPdXXosk
November 18th 2017, 7:11pm
TranscriptDaily @TranscriptDaily
Acorda Therapeutics, Inc. $ACOR PT Lowered to $19.00 at J P Morgan Chase & Co https://t.co/9U9AfSd1zY
November 18th 2017, 2:11pm
SleekMoneycom @SleekMoneycom
Acorda Therapeutics, Inc. $ACOR Downgraded by ValuEngine https://t.co/qLG2ySNTqw
November 18th 2017, 2:11pm
dispatchtribune @dispatchtribune
Acorda Therapeutics, Inc. $ACOR PT Lowered to $19.00 at J P Morgan Chase & Co https://t.co/gbgD1bNjjS
November 18th 2017, 2:11pm
wosaikeneriki @wosaikeneriki
Acorda Therapeutics $ACOR Market Value Declined While Citigroup Has Lifted by $2.11 Million Its Stake ...
November 18th 2017, 1:11pm
dakotafinancial @dakotafinancial
Oppenheimer Holdings, Inc. Analysts Give Acorda Therapeutics, Inc. $ACOR a $18.00 Price Target https://t.co/AGlIoPJDeE
November 18th 2017, 12:11pm
TheMarketsDaily @TheMarketsDaily
Cantor Fitzgerald Trims Acorda Therapeutics, Inc. $ACOR Target Price to $16.00 https://t.co/V32SnkxOt3
November 18th 2017, 12:11pm
ConsumerFeed @ConsumerFeed
Oppenheimer Holdings, Inc. Analysts Give Acorda Therapeutics, Inc. $ACOR a $18.00 Price Target https://t.co/VWNiPZ6ZQF
November 18th 2017, 12:11pm
ohmsonite @ohmsonite
In Apr, $ACOR has 4 of 5 Ampyra patents invalidated. Investors drove price down to $14. Now TOZADENANT has safety i… https://t.co/XGVLfi9jMH
November 18th 2017, 12:11pm
stocknewstimes @stocknewstimes
Q1 2018 EPS Estimates for Acorda Therapeutics, Inc. $ACOR Lifted by Leerink Swann https://t.co/UDWQNnMN9T
November 18th 2017, 11:11am
noritsunagirota @noritsunagirota
Hikari Power LTD Has Upped Its Acorda Therapeutics $ACOR Holding https://t.co/JBvJJlv3sL
November 18th 2017, 10:11am
TheMarketsDaily @TheMarketsDaily
Q1 2018 EPS Estimates for Acorda Therapeutics, Inc. $ACOR Lifted by Leerink Swann https://t.co/qkNEUwnSNW
November 18th 2017, 9:11am
wlstcom @wlstcom
3 Things In Biotech You Should Learn Today: November 18, 2017 #ACOR #RARE #RHHBF $ACOR https://t.co/WKpNAe4UFg https://t.co/kYZYiyx9zc
November 18th 2017, 9:11am
WatchlistN @WatchlistN
Acorda Therapeutics, Inc. Expected to Earn Q2 2018 Earnings of $0.84 Per Share $ACOR https://t.co/fHNv16DvtQ
November 18th 2017, 8:11am
TheMarketsDaily @TheMarketsDaily
Acorda Therapeutics, Inc. $ACOR Rating Lowered to Underperform at Raymond James Financial, Inc. https://t.co/dG7cFreA3G
November 18th 2017, 8:11am
storminvestor @storminvestor
Acorda Therapeutics, Inc. $ACOR Shares Gap Down on Analyst Downgrade https://t.co/GsaFktxFEp
November 18th 2017, 1:11am
TickerReport @TickerReport
Acorda Therapeutics, Inc. $ACOR Downgraded by Raymond James Financial, Inc. to “Underperform” https://t.co/x3wVj3guF4
November 18th 2017, 12:11am
TickerReport @TickerReport
Acorda Therapeutics, Inc. $ACOR Downgraded by Raymond James Financial, Inc. to “Underperform” https://t.co/bd6oPHkvn3
November 18th 2017, 12:11am
emq_news @emq_news
Acorda Therapeutics, Inc. $ACOR Downgraded by Raymond James Financial, Inc. to “Underperform” https://t.co/kGhLJhLtDa
November 18th 2017, 12:11am
TickerReport @TickerReport
Acorda Therapeutics, Inc. $ACOR Downgraded to Hold at Stifel Nicolaus https://t.co/vyz7UFL61V
November 18th 2017, 12:11am
emq_news @emq_news
Acorda Therapeutics, Inc. $ACOR Downgraded to Hold at Stifel Nicolaus https://t.co/waysyK85r1
November 18th 2017, 12:11am
TickerReport @TickerReport
Acorda Therapeutics, Inc. $ACOR Downgraded to Hold at Stifel Nicolaus https://t.co/M8rwyP1vs0
November 18th 2017, 12:11am
storminvestor @storminvestor
Acorda Therapeutics, Inc. $ACOR Given a $17.00 Price Target at Janney Montgomery Scott https://t.co/oDzXgR7sph
November 18th 2017, 12:11am
CFinancialNews @CFinancialNews
Leerink Swann Comments on Acorda Therapeutics, Inc.’s Q2 2018 Earnings $ACOR https://t.co/UBJWp1Wv58
November 17th 2017, 11:11pm
TheMarketsDaily @TheMarketsDaily
Leerink Swann Comments on Acorda Therapeutics, Inc.’s Q2 2018 Earnings $ACOR https://t.co/guskAumPRq
November 17th 2017, 11:11pm
intercooleronli @intercooleronli
Leerink Swann Comments on Acorda Therapeutics, Inc.’s Q2 2018 Earnings $ACOR https://t.co/Ttnyc2mGhC
November 17th 2017, 11:11pm
ConsumerFeed @ConsumerFeed
Leerink Swann Comments on Acorda Therapeutics, Inc.’s Q2 2018 Earnings $ACOR https://t.co/WUG4d37Ov6 #acn
November 17th 2017, 11:11pm
stocknewstimes @stocknewstimes
Head to Head Review: Acorda Therapeutics $ACOR vs. Its Rivals https://t.co/QU7kV4VvQM
November 17th 2017, 11:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.